ILEA000184543: New coronavirus

Japan gov't panel approves 2 iPS-derived drugs

OSAKA, Japan, Feb. 19 Kyodo - University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university. (Kyodo)

[Breaking News]World Exposition in Osaka

OSAKA, Japan, June 5 Kyodo - Video taken on June 5, 2025, shows a water-playing area for children in the Forest of Tranquility at the World Exposition in Osaka. Public access to a pond in the area is currently prohibited following the detection of legionella bacteria 20 times more than the standard. (Kyodo)

Lab to study aging mechanism

Japanese precision equipment maker Shimadzu Corp. and Tohoku University establish a lab at the state university's campus in Sendai, northeastern Japan, on April 18, 2025, to jointly study the mechanism of aging. The lab aims to develop anti-aging therapies, medicine and food through the study until March 2027.

Lab to study aging mechanism

Japanese precision equipment maker Shimadzu Corp. and Tohoku University establish a lab at the state university's campus in Sendai, northeastern Japan, on April 18, 2025, to jointly study the mechanism of aging. The lab aims to develop anti-aging therapies, medicine and food through the study until March 2027.